Answers are grounded in this paper and cite their sources.
Antidepressants compete at several neurotransmitter receptor binding site, but drug affinities do not correlate with clinical efficacy. Long-term, but not short-term, antidepressant treatment decreases the numbers of both serotonin and beta-adrenergic receptors. The decrease in the number of receptor sites is most marked for [3H]spiroperidol-labeled serotonin receptors and is characteristic for antidepressants of several classes.
No takes yet. Share an insight, caveat, or question.
Peroutka et al. (1980) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: